- Home
- INMB vs PETS Comparison
INMB vs PETS Comparison
Compare INMB & PETS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INMB
- PETS
- Stock Information
- Founded
- INMB 2015
- PETS 1996
- Country
- INMB United States
- PETS United States
- Employees
- INMB N/A
- PETS N/A
- Industry
- INMB Biotechnology: Pharmaceutical Preparations
- PETS Retail-Drug Stores and Proprietary Stores
- Sector
- INMB Health Care
- PETS Consumer Staples
- Exchange
- INMB Nasdaq
- PETS Nasdaq
- Market Cap
- INMB 103.1M
- PETS 105.6M
- IPO Year
- INMB 2019
- PETS N/A
- Fundamental
- Price
- INMB $6.53
- PETS $5.17
- Analyst Decision
- INMB Strong Buy
- PETS Sell
- Analyst Count
- INMB 2
- PETS 2
- Target Price
- INMB $21.00
- PETS $3.50
- AVG Volume (30 Days)
- INMB 369.6K
- PETS 249.5K
- Earning Date
- INMB 10-31-2024
- PETS 02-06-2025
- Dividend Yield
- INMB N/A
- PETS N/A
- EPS Growth
- INMB N/A
- PETS N/A
- EPS
- INMB N/A
- PETS N/A
- Revenue
- INMB $42,000.00
- PETS $259,343,000.00
- Revenue This Year
- INMB N/A
- PETS N/A
- Revenue Next Year
- INMB N/A
- PETS $3.36
- P/E Ratio
- INMB N/A
- PETS N/A
- Revenue Growth
- INMB N/A
- PETS N/A
- 52 Week Low
- INMB $4.32
- PETS $2.90
- 52 Week High
- INMB $14.74
- PETS $7.24
- Technical
- Relative Strength Index (RSI)
- INMB 64.22
- PETS 54.06
- Support Level
- INMB $6.04
- PETS $4.74
- Resistance Level
- INMB $6.83
- PETS $5.30
- Average True Range (ATR)
- INMB 0.56
- PETS 0.23
- MACD
- INMB 0.17
- PETS 0.03
- Stochastic Oscillator
- INMB 86.76
- PETS 82.19
About INMB INmune Bio Inc. Common stock
INmune Bio Inc is a clinical-stage biotechnology company. It is engaged in the development of new immunotherapies that reprogram a patient's innate immune system to allow immune system to fight cancer. The company's pipeline products includeINKmune, INBO3, XPro1595, LIVNate, and others.
About PETS PetMed Express Inc.
PetMed Express Inc along with its subsidiaries is a nationwide pet pharmacy. The company markets prescription and non-prescription pet medications, health products, and supplies for dogs and cats, direct to the consumer. The company generates its revenue by selling pet medications and pet supplies mainly to retail consumers.